We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
-0.67%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$198M
AUM Growth
-$215M
Cap. Flow
-$211M
Cap. Flow %
-106.36%
Top 10 Hldgs %
35.51%
Holding
63
New
3
Increased
15
Reduced
20
Closed
19

Top Buys

Rank Stock Value
1
ALC icon
Alcon
ALC
+$6M
2
GRFS
Grifois
GRFS
+$4.18M
3
ZTS icon
Zoetis
ZTS
+$3.62M
4
CI icon
Cigna
CI
+$3.25M
5
HCA icon
HCA Healthcare
HCA
+$2.58M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$6.5M
2
MOH icon
Molina Healthcare
MOH
+$5.73M
3
ELAN icon
Elanco Animal Health
ELAN
+$5.07M
4
WMGI
Wright Medical Group Inc
WMGI
+$4.77M
5
SNN icon
Smith & Nephew
SNN
+$4.35M

Sector Composition

Rank Sector Weight
1 Healthcare 95.79%
2 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDT icon
26
Medtronic
MDT
$116B
$4.34M 2.19%
40,000
+10,000
+33% +$1.04M
INCY icon
27
Incyte
INCY
$24.5B
$4.08M 2.06%
55,000
+10,000
+22% +$808K
THC icon
28
Tenet Healthcare
THC
$20.9B
$3.87M 1.95%
175,000
+5,000
+3% +$107K
ZTS icon
29
Zoetis
ZTS
$31.1B
$3.74M 1.89%
+30,000
New +$3.62M
ELV icon
30
Elevance Health
ELV
$84.7B
$3.6M 1.82%
15,000
-10,000
-40% -$2.74M
AZN icon
31
AstraZeneca
AZN
$246B
$3.57M 1.8%
40,000
-10,000
-20% -$867K
ISRG icon
32
Intuitive Surgical
ISRG
$142B
$3.3M 1.67%
18,354
-4,146
-18% -$717K
HRC
33
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$3.16M 1.59%
30,000
+15,000
+100% +$1.58M
CI icon
34
Cigna
CI
$72.4B
$3.04M 1.53%
+20,000
New +$3.25M
BMRN icon
35
BioMarin Pharmaceuticals
BMRN
$13.5B
$3.03M 1.53%
45,000
+10,000
+29% +$770K
CNC icon
36
Centene
CNC
$32.1B
$1.73M 0.87%
40,000
-20,300
-34% -$989K
SGEN
37
DELISTED
Seagen Inc. Common Stock
SGEN
$1.71M 0.86%
20,000
-15,000
-43% -$1.1M
BPMC
38
DELISTED
Blueprint Medicines
BPMC
$1.47M 0.74%
20,000
-10,000
-33% -$864K
ACAD icon
39
Acadia Pharmaceuticals
ACAD
$5.07B
$1.44M 0.73%
40,000
-10,000
-20% -$303K
SAGE
40
DELISTED
Sage Therapeutics
SAGE
$1.4M 0.71%
10,000
-7,500
-43% -$1.25M
TDOC icon
41
Teladoc Health
TDOC
$1.24B
$1.29M 0.65%
19,100
-10,900
-36% -$717K
SRPT icon
42
Sarepta Therapeutics
SRPT
$1.92B
$1.13M 0.57%
15,000
-12,500
-45% -$1.48M
CHRS icon
43
Coherus Oncology
CHRS
$187M
$918K 0.46%
45,296
-99,704
-69% -$1.99M
A icon
44
Agilent Technologies
A
$42.2B
$766K 0.39%
10,000
-35,000
-78% -$2.52M
AGIO icon
45
Agios Pharmaceuticals
AGIO
$1.95B
– –
-30,000
Closed -$1.5M
AMED
46
DELISTED
Amedisys
AMED
– –
-20,000
Closed -$2.43M
BHC icon
47
Bausch Health
BHC
$2.33B
– –
-140,000
Closed -$3.53M
BLUE
48
DELISTED
bluebird bio
BLUE
– –
-1,930
Closed -$3.18M
ELAN icon
49
Elanco Animal Health
ELAN
$11.4B
– –
-150,000
Closed -$5.07M
EXAS
50
DELISTED
Exact Sciences
EXAS
– –
-20,000
Closed -$2.36M
1
2
3

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
9C
9823 Capital Dallas, Texas $132M AUM
STFP
Signal Tree Financial Partners Copley, Ohio $132M AUM 15.43% 1-Year Est. Return
ADEF
ABS Direct Equity Fund Stamford, Connecticut $131M AUM 7.53% 1-Year Est. Return
AC
Aldebaran Capital Carmel, Indiana $131M AUM 34.7% 1-Year Est. Return

Sivik Global Healthcare's Q3 2019 Portfolio in Review

As of Q3 2019, Sivik Global Healthcare held 63 positions worth $198M, down 52% from $414M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Sivik Global Healthcare withdrew a net $211M in Q3 2019, closing 19 positions and reducing 20 holdings. Its most notable exit was Pfizer, an estimated $6.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 58% a quarter earlier, followed by Energy.

Against the trend, Sivik Global Healthcare opened a new position in Alcon worth $5.83M.

  • Sivik Global Healthcare's largest Q3 2019 buy was Alcon: 100,000 shares worth $5.83M.
  • Sivik Global Healthcare added most to Grifois in Q3 2019, an estimated $4.18M increase.
  • Sivik Global Healthcare's biggest Q3 2019 reduction was Becton Dickinson, cutting an estimated $3.16M.
  • Sivik Global Healthcare fully exited Pfizer in Q3 2019, selling an estimated $6.5M.
  • Sivik Global Healthcare's ten largest holdings make up 36% of its $198M portfolio in Q3 2019.
  • Sivik Global Healthcare opened 3 new positions and closed 19 in Q3 2019.
  • Sivik Global Healthcare's portfolio value fell 52% quarter-over-quarter to $198M.

Based on Sivik Global Healthcare's 13F filing for Q3 2019, filed 12 Nov 2019.